Global /United States /Healthcare /Medical Devices /BIO
chevron_leftBack

Bio-Rad Laboratories, Inc.

BIO
NYSE: BIO Delayed
249.66USD 1.9%
As of 24 April 2025, Bio-Rad Laboratories, Inc. has a market cap of $6.97B USD, ranking #2232 globally and #765 in the United States. It ranks #195 in the Healthcare sector, and #23 in the Medical Devices industry.
Global Rank
2232
Country Rank
765
Sector Rank
195
Industry Rank
23
Key Stats
Market Cap
$6.97BUSD
Enterprise Value
$6.68BUSD
Revenue (TTM)
$2.57BUSD
EBITDA (TTM)
$420.6MUSD
Net Income (TTM)
-$1.84BUSD
EBITDA Margin
16%
Profit Margin
-72%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Norman Schwartz open_in_new
Employees
7,700
Founded
1952
Website
bio-rad.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.9% 1.8% -2.7% -31% -27% -11%
Upcoming Earnings
Earnings Date
Thu, May 1
Earnings Time
bedtime After Close
EPS Estimate
$1.79 -22% yoy
Revenue Estimate
$573.01M -6.2% yoy

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
BIO
Bio-Rad Laboratories Inc Class A
ISIN: US0905722072
Shares Out.:
22.941M1 Shares Float: 19.197M2
TV:
SA:
YF:
BIO
GF:
NQ:
BIO
BA:
BIO
MS:
249.66 USD
NYSE
MIC: XNYS
BIO.B
Bio-Rad Laboratories Inc
ISIN: US0905721082
Shares Out.:
5.07M1 Shares Float: 99.064K2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
234.41 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
Abbott Laboratories
ABT
$225.18B
3K%
Boston Scientific Corp.
BSX
$146.31B
2K%
Stryker Corp.
SYK
$136.3B
2K%
Edwards Lifesciences Corp.
EW
$41.27B
492%
DexCom, Inc.
DXCM
$26.22B
276%
Industry: Medical Devices (Global)
Name
Market Cap diff.
Medtronic plc
MDT
$107.41B
1K%
Siemens Healthineers AG
SHL
$57.76B
50.97B EUR
729%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
$36.05B
262.7B CNY
417%
Koninklijke Philips N.V.
PHIA
$22.27B
19.57B EUR
220%
STERIS plc
STE
$22.0B
216%